{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6678, 
        6691
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6976, 
        6989
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6692, 
        6701
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6776, 
        6785
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6990, 
        6999
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7673, 
        7687
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7996, 
        8005
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6505, 
        6528
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6530, 
        6546
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        8193, 
        8213
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        8215, 
        8223
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6578, 
        6605
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6607, 
        6617
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6626, 
        6630
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6879, 
        6883
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7606, 
        7610
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        8151, 
        8155
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        8175, 
        8179
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        546, 
        575
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        577, 
        594
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4624, 
        4659
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4661, 
        4673
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        8095, 
        8121
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        8123, 
        8141
      ]
    }
  ], 
  "Negative Findings Phraseology (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Ben,Model - 20171123_CDC_B1B2_4,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6763, 
        6785
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Ben,Model - 20171123_CDC_B1B2_4,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7983, 
        8005
      ]
    }
  ], 
  "Neoplasm Descriptive Grade (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6656, 
        6677
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7651, 
        7672
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6620, 
        6624
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7600, 
        7604
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6631, 
        6641
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7611, 
        7621
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        8156, 
        8166
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        8180, 
        8190
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        4674, 
        4675
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        5004, 
        5005
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6617, 
        6619
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7597, 
        7599
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        8143, 
        8150
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        8167, 
        8174
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        8223, 
        8224
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        8297, 
        8298
      ]
    }
  ], 
  "__text": "MSH|^~\\&|LABCORP-CORP|LABCORP^34D0655059^CLIA|Cancer Registry|State|201706010938|State006|ORU^R01|2017060107093839521000|P|2.3.1\nPID|1||^^^^SS^~11111111^^^^PI^|ALTERNATE ID|TEST^PATIENT^A||19500601|M||2054-5^Black or African American^CDC^^^|1234 Test Road^^ALBANY^NY^12201||^^^^^222^1234567|||||||\nORC|RE||111A1111111||||||||||||||||||Ordering Facility Name^^L|2222 W. Test Road^^Test^TX^77025|^^^^^111^1234567||\nOBR|1||111A1111111|^^^111111^Pathology Report^L|||201705301335|||||||20090115||Ordering Provider Name||||||20170530|||F|||||||\n\n\n\n\n\n\nPath report.gross observation\n\nGross description: The specimens are received in formalin, labeled with the patient's name and sublabeled as the following: (1) left lower lobe; (2) left upper lobe. \n (1) The specimen consists of a left lung lower lobe (223 grams, 13.5 x  10.5 x 9.2 cm) with a stapled parenchymal resection margin. The pleura  is gray-black, smooth and glistening with focally pale gray puckered  areas (2.5 x 1.0 cm-2.5 x 2.3 cm). The irregular areas involve the  superoposterior, anterolateral, and lateral superior and inferior  aspects. The superoposterior area is 2.2 cm from the parenchymal,  4.8 cm from the vascular, and 5.1 cm from the bronchial resection  margins. The underlying parenchyma is pale tan with black speckles.  The anterolateral irregular area is approximately 5 cm inferior from  the first area and is 3.2 cm from the parenchymal, 3.8 cm from the  vascular, and 4.2 cm from the bronchial resection margins. The  underlying parenchyma is pale brown, focally congested, and contains a  tan-white and black solid partially friable irregular mass (2.7 x 2.5  x 2.5 cm). The mass is 1.2 cm from the parenchymal, 3.1 cm from the  vascular, and 4.2 cm from the bronchial resection margins. The mass  causes the overlying pleura to pucker. It cannot be grossly determined  if the mass invades the parietal pleura. The irregular area involving  the medial, inferior and superior aspects of the base is approximately  7.3 cm from the mass, 5.1 cm from the parenchymal, 6.8 cm from the  vascular, and 6.2 cm from the bronchial resection margins. The  underlying parenchyma is pale tan and congested. No other nodules,  masses or irregular areas are identified. Ink code: black-resection  margin. Section code: (A1) bronchial and vascular resection margins;  (A2-A3, A4-A5) superoposterior area, representative; (A6-A7, A8-A9,  A10-A11, A12-A14) mass (anterolateral area) representative sections  submitted superior to inferior; (A15, A16) medial, inferior and  superior area involving the base, representative; (A17, A18) composite  section of mass in relation to blue inked pleural puckering, bisected;  (A19) two additional peribronchial lymph nodes. (2) The specimen consists of a left lung upper lobe (256 grams, 19.5 x  10.5 x 5.5 cm) with stapled resection margins. The pleura is gray-  black and glistening with a focally pale gray puckered area (2.2 x 2.0  x 0.5 cm) involving the anterior lingula. This area is 5.5 cm from  the parenchymal, 8.5 cm from the vascular, and 6.3 cm from the  bronchial resection margins. The underlying parenchyma is red-brown,  focally firm and fibrous with black speckles. The hilar parenchyma is  red-brown and contains a gray-yellow and black, firm, irregular mass  (2.2 x 1.7 x 1.4 cm) located in between the bronchus and vessels. The  mass is 0.6 cm from the parenchymal, 1.2 cm from the bronchial, and  1.7 cm from the vascular resection margins. The mass pushes outward on  the pleura, however, it cannot be grossly determined if the parietal  pleura is invaded. The mass does not appear to extend into the  bronchus or vessels. The remaining parenchyma is red-brown with black  speckles and minimal mucous plugging. Ink code: black-resection  margin. Section code: (B1) vascular resection margins; (B2) bronchial  resection margin; (B3-B5) irregular area involving the lingula,  serially sectioned, representative; (B6-B13) mass, representative;  (B14-B17) parenchyma with pleura, representative, (B18, B19)  peribronchial lymph node candidates; (B20, B21) sequential sections  of mass in relation to bronchus; (B22) additional sampling of mass;  (B23) subpleural mucoid nodule. \n Note: Both specimens were inflated with formalin overnight prior to grossing and after being weighed. No hilar lymph nodes are identified. All measurements are taken after the removal of the resection margin staple lines. The specimens were viewed by Dr prior to grossing for gross consultation. (JM:cmc10 717574) (MS:jw 720099) /MRV\n\n\nPayment procedure\n\nCPT                            .883071, 883072, W20061, W20542\n\n\nPath report.microscopic observation\n\nMicroscopic: A) Sections are of lung parenchyma infiltrated by a poorly differentiated carcinoma with a nodular growth pattern. A few foci demonstrate kertinization / squamous pearls and other areas have prominence of intercelluar bridges. Though the mass approaches the pleura, it does not involve the elastic layer of the visceral pleura. \n B) Histologic sections are of a poorly differentiated carcinoma with a multilobulated yet fairly well circumscribed leading edge which involves the parabronchial region. Several areas in the periphery of the carcinoma have surrounding lymphoid tissue. The carcinoma does not involve the bronchi or great vessels. There are no areas of kertinization or intercellular brides identified. To further classify the lesion, a panel of immunohistochemistry (each with an appropriately positive control) was performed. The poorly differentiated carcinoma is positive for pankeratin (OSCAR), keratin 7 and villin (variable) protein expression by immunohistochemistry. The carcinoma cells are negative for keratin 5/6, keratin 20, p40, TTF-1, napsin-A, chromagranin, synaptophysin, CDX2, PSA, GATA3 and PAX-8 protein expression by immunohistochemistry. Overall, this immunophenotype is consistent with adenocarcinoma; however, no specific origin declares itself. There is no evidence of squamous or neuroendocrine differentiation. \n * This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded as investigational or for research.\n\n\nPATHOLOGIST NAME\n\nElectronically signed: Pathologist name, Pathologist\n\n\nDiagnosis ICD code\n\nPathologist provided ICD-10:C34.12, C34.32\n\n\nPath report.relevant Hx\n\nClinical history: LUNG NEOPLASM MALIGNANT LLL\n\n\nPath report.final diagnosis\n\nDiagnosis:A. Lung, Left Lower Lobe, Lobectomy:   Poorly differentiated squamous cell carcinoma; see cancer case   summary.   Four parabronchial lymph nodes negative for carcinoma. \n  CANCER CASE SUMMARY:  Specimen: Lower Lobe.  Procedure: Lobectomy:  Specimen laterality: Left.  Tumor site: Lower lobe.  Tumor size: 2.3 cm.  Tumor focality: Unifocal.  Histologic type: Squamous cell carcinoma.  Histologic grade: G3; poorly differentiated with focal keratinization.  Visceral pleural invasion: Not identified.  Tumor extension: Not identified.  MARGINS:  Distance of invasive carcinoma from closest margin: 12 mm,   parenchymal.  Bronchial margin: Uninvolved by invasive carcinoma and carcinoma in   situ.  Vascular margin: Uninvolved by invasive carcinoma.  Parenchymal margin: Uninvolved by invasive carcinoma.  Lymphovascular invasion: Present.  PATHOLOGIC STAGE:  Primary tumor: pT1b.  Regional lymph nodes: pN0  Number of lymph nodes examined: 2.  Number of lymph nodes involved: 0. \n B. Lung, Left Upper Lobe, Completion Pneumonectomy:   Poorly differentiated adenocarcinoma with the following features:   Size: 2.2 cm.   Extent: Well-circumscribed carcinoma confined to peribronchial area;    see comment.   Margin: 0.9 cm from hilar parenchyma margin (allowing for trimmed    staple line).   Lymphovascular invasion: Present.   Five distinct parabronchial lymph nodes negative for carcinoma. MRV/08/07/2017 **********************************************************************\n\n\nPath report.site of origin\n\nMaterial submitted: PART A: LEFT LOWER LOBE PART B: LEFT UPPER LOBE\n\n\nPath report.comments\n\nComment:A) PD-L1 studies are pending and results will be issued in an addendum. \n B) Interestingly, the carcinoma identified in the left upper lobe of lung is adenocarcinoma and appears distinct from the squamous cell carcinoma see in the left lower lobe. Additinonally there is immunophenotypic evidence of enteric differentiation. The carcinoma is confined to the peribronchial space and though it is multinodular, appears well circumscribed. In foci of the periphery of the carcinoma has lymphoid tissue suggesting that the entire lesion may represent parabronchial lymph nodes replaced by carcinoima. No other adenocarcinoma or adenocarcinoma in situ is identified in either the left lower or left upper lobe of lung. Given the enteric phenotype (positive for villin), this raises the possibility of a metastasis from another site including upper GI origin; however, lung primary adenocarcinoma certainly remains a possibility. Correlation with clinical imaging and endoscopic findings remains the best method to determine the primary site. \n Given the distinct carcinoma in the upper lobe, PD-L1 studies will also be performed on this part and results issued in an addendum. \n As a part of routine quality assurance, Dr. has reviewed select slides from each part and agrees with the above diagnosis.\n\n\n"
}